Stenting with intravenous abciximab infusion for the treatment of left main coronary artery thrombosis during coronary angioplasty

J Invasive Cardiol. 2001 Feb;13(2):107-10.

Abstract

A 67-year-old female patient complained of exertional precordial chest pain with radiation to the left shoulder occurring over a two-month period. An acute non-Q wave anterior myocardial infarction was diagnosed. On the third day of admission, coronary angiography revealed two-vessel disease with 73% luminal narrowing of the proximal left anterior descending coronary artery and 50% luminal narrowing of the mid-right coronary artery. The initial attempt to implant a NIR stent (Boston Scientific/Scimed, Inc., Maple Grove, Minnesota) was unsuccessful. We report on the successful rescue implantation of two MAC (Maximum Arterial re-Creation) stents (Advanced Medical Technologies, Germany), in conjunction with the infusion of abciximab for the treatment of an abrupt closure due to thrombus of the left main coronary artery.

Publication types

  • Case Reports

MeSH terms

  • Abciximab
  • Aged
  • Angioplasty, Balloon, Coronary*
  • Antibodies, Monoclonal / therapeutic use*
  • Coronary Angiography
  • Coronary Thrombosis / diagnostic imaging
  • Coronary Thrombosis / therapy*
  • Female
  • Humans
  • Immunoglobulin Fab Fragments / therapeutic use*
  • Infusions, Intravenous
  • Platelet Glycoprotein GPIIb-IIIa Complex / therapeutic use*
  • Stents*

Substances

  • Antibodies, Monoclonal
  • Immunoglobulin Fab Fragments
  • Platelet Glycoprotein GPIIb-IIIa Complex
  • Abciximab